Purchase Order 36C24925P0634

Award Date 6/24/25
Potential Completion Date 7/24/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Louisville, KY 40206, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Plus transducers, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract is a firm-fixed-price purchase order with a period of performance...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to the prime contractor Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Transducer, a device that delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract has a firm fixed price and an ultimate...
This federal contract award, valued at $16,582.91, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 (VISN 8) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the procurement of Optune Plus Transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat glioblastoma, mesothelioma, and other solid tumor cancers in a non-invasive manner. The...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 (VISN 15) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the rental extension of Optune Plus Transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat glioblastoma, mesothelioma, and other solid tumor cancers. The contract is a firm...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price delivery order is for the provision of Novocure's Optune Plus transducer devices, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma in veteran patients. The award is part of a larger $28.85 million Federal...
This federal contract award, valued at $33,165.82, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's Optune Plus system, which delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. This is a firm-fixed-price purchase order with a period of performance running through...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is a firm fixed-price purchase order for the delivery of Novocure's Optune medical device system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract has a ceiling value of $49,748.73 and a completion...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. This contract does not utilize any set-aside designations and is being...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the delivery of Optune Plus transducers, a component of Novocure's Tumor Treating Fields (TTFields) therapy devices used to treat glioblastoma and mesothelioma. The contract is a delivery order issued under Novocure's 5-year Federal Supply Schedule (FSS)...
This federal contract award to Novocure Inc., a foreign-owned medical device manufacturer, is a delivery order under the company's existing Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune system, a medical device that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma....

This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 (VISN 9) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the delivery of Optune PLUS Transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, including glioblastoma and mesothelioma.

The contract is structured as a firm fixed-price purchase order, with a completion date of July 24, 2025. Novocure is the prime contractor and sole provider under this award, with no subcontractors involved. This contract award is part of a larger $28.85 million Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) that Novocure holds with the VA VHA, which serves as a primary procurement vehicle for the VA to obtain Novocure's specialized medical technologies. The contract does not utilize any set-aside designations, likely due to the specialized nature of Novocure's cancer treatment offerings.

Generated 6/29/25, 1:19 AM